Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| UTI - Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | UTI | Axis |
| NAV | ₹401.8398 | ₹22.8900 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 13.9 years | 6.8 years |
| Expense ratio | 1.3% | 1.8% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 83.00 | 27.80 |
Returns
| UTI - Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| 1 month | +11.37% | +6.66% |
| 3 months | +3.73% | −0.17% |
| 6 months | +13.95% | +4.33% |
| YTD | +24.95% | −3.13% |
| 1 year | +22.75% | −3.09% |
| 3 years (CAGR) | +23.24% | +8.47% |
| 5 years (CAGR) | +17.91% | +5.41% |
| 10 years (CAGR) | +15.97% | — |
| Since launch | +16.58% | +12.87% |
Risk
| UTI - Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| Volatility | 15.4% | 14.1% |
| Downside volatility | 8.9% | 10.3% |
| Sharpe | 1.09 | 0.14 |
| Sortino | 1.89 | 0.19 |
| Calmar | 1.46 | 0.48 |
| Return / risk | 1.51 | 0.60 |
| Deepest fall | −27.10% | −24.30% |
| Days to recover | 35 | 517 |
| Below its high | +0.00% | −7.66% |
Against benchmark
| UTI - Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| Alpha | +3.12% | — |
| Beta | 0.91 | — |
| R² | 85.2% | — |
| Up capture | 92.5% | — |
| Down capture | 72.0% | — |
| Tracking error | 6.1% | — |
| Information ratio | 0.31 | — |
| Treynor | 0.17 | — |
Consistency
| UTI - Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| Best 1-year | +86.35% | +70.80% |
| Middle 1-year | +13.05% | +9.41% |
| Worst 1-year | −18.18% | −16.36% |
| 1-year periods with a loss | 30.7% | 28.8% |
| Middle 3-year | +18.03% | +13.11% |
| Positive months | 66.7% | 63.9% |
| Best day | +3.11% | +3.71% |
| Worst day | −3.39% | −3.53% |
| Worst 5% day | −1.43% | −1.22% |
| Positive days | 56.8% | 52.6% |
| NAVs a year | 247 | 251 |
SIP of ₹10,000 a month
| UTI - Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| 5-year XIRR | +22.23% | +7.32% |
| 5-year value | ₹10,53,070 | ₹7,24,420 |
| 3-year XIRR | +19.85% | +3.16% |
| 1-year XIRR | +30.95% | +2.79% |
Holdings overlap i
| UTI - Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| UTI - Healthcare Fund | — | 10% |
| Axis ESG Integration Strategy Fund | 10% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | UTI - Healthcare Fund | Axis ESG Integration Strategy Fund |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 7.44% | 2.77% |
| Anthem Biosciences Limited | 1.74% | 1.67% |
| Biocon Limited | 1.53% | 2.29% |
| Metropolis Healthcare Limited | 1.47% | 1.74% |
| IPCA Laboratories Limited | 2.54% | 1.35% |
| Alkem Laboratories Limited | 3.66% | 0.73% |
| Gland Pharma Limited | 3.89% | 0.39% |
Sectors and company size
| UTI - Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| Large companies | 19.2% | 49.8% |
| Mid companies | 35.3% | 13.1% |
| Small companies | 38.9% | 21.2% |
| Top 10 holdings | 46.6% | 49.5% |
| Largest sector | Pharmaceuticals & Biotechnology 69% | Finance 13% |